In our cohort of patients with NAFLD, we found that the addition of serum MMP7 improved the diagnostic performance of the ELF score, increasing the sensitivity by 8.5% in the total cohort and by 20% in patients over 60, at a 10% false positive rate (90% specificity). This evidence concerns the gene MMP7 and metabolic dysfunction-associated steatotic liver disease.